RA
BTMD icon

Royce & Associates’s Biote Corp BTMD Stock Holding History

Royce & Associates’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,270
Closed -$39.8K – 769
2025
Q3 		$39.8K Buy
13,270
+1,021
+8% +$3.65K ﹤0.01% 762
2025
Q2 		$49.2K Sell
12,249
-1,021
-8% -$3.77K ﹤0.01% 777
2025
Q1 		$44.2K Hold
13,270
– – ﹤0.01% 790
2024
Q4 		$82K Sell
13,270
-1,020
-7% -$5.93K ﹤0.01% 815
2024
Q3 		$79.7K Hold
14,290
– – ﹤0.01% 851
2024
Q2 		$107K Hold
14,290
– – ﹤0.01% 850
2024
Q1 		$82.9K Buy
+14,290
New +$71.6K ﹤0.01% 861

Other funds holding BTMD

3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royce & Associates's BTMD Position: Q4 2025 in Review

Royce & Associates sold out of Biote Corp (BTMD) in Q4 2025, closing a stake of 13,270 shares — an estimated $39.8K sold.

Royce & Associates first reported a position in BTMD in Q1 2024 and held it in 7 quarters. The position peaked at $107K in Q2 2024. 85 funds tracked by Wall St. Rank hold BTMD as of Q4 2025.

  • Royce & Associates reported no remaining Biote Corp position as of Q4 2025 after selling out during the quarter.
  • Royce & Associates sold 13,270 Biote Corp shares in Q4 2025, an estimated $39.8K.
  • Royce & Associates first reported a position in Biote Corp in Q1 2024 and held it in 7 quarters.
  • Royce & Associates's Biote Corp position peaked at $107K in Q2 2024.
  • 85 funds tracked by Wall St. Rank held Biote Corp as of Q4 2025.

Based on Royce & Associates's 13F filing for Q4 2025, filed 9 Feb 2026.